Correction
Correction: Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus
-
* Corresponding author: Juliana Levy julevy@ig.com.br
Department of Medicine, Diabetes Unit, State University of Rio de Janeiro, Rio de Janeiro, Brazil
Diabetology & Metabolic Syndrome 2010, 2:57 doi:10.1186/1758-5996-2-57
The electronic version of this article is the complete one and can be found online at: http://www.dmsjournal.com/content/2/1/57
| Received: | 24 August 2010 |
| Accepted: | 25 August 2010 |
| Published: | 25 August 2010 |
© 2010 Levy et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Correction
Since publication of our article [1], we have noticed that amendments to the second sentence of the "Study Design" section are required as this should read as follows:
"Approved by the local ethics committee, patient enrolment was restricted to the following patients: those aged 18 years and greater and taking immediate release metformin alone or in combination with other oral agents, those excluded had symptoms of poor diabetes control, were pregnant, had serum creatinine levels >1.3 mg/dL (female) or 1.4 mg/dL (male), nephropathy, evidence of hepatic disease or history of alcohol abuse."
We apologize for any inconvenience or confusion that this may have caused.
References
-
Levy J, Cobas RA, Gomes MB: Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus.
Diabetol Metab Syndr 2010, 2:16. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text